Duke Cancer Center Cary — Cary, North Carolina

Duke Cancer Center Cary is a clinical research site located in Cary, North Carolina, United States 27518.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Duke Cancer Center Cary has participated in 30 clinical trials with 27 currently active.

Therapeutic areas: Endometrial Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma.

Sponsors: National Cancer Institute (NCI), Andrew J. Armstrong, MD, NRG Oncology.

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Cancer Center Cary?

Duke Cancer Center Cary has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Cancer Center Cary conducted?

Duke Cancer Center Cary has 30 clinical trials on record, with 27 currently active. Their work covers Endometrial Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma.

Is Duke Cancer Center Cary accredited by Crixeo Health?

Yes — Duke Cancer Center Cary holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Duke Cancer Center Cary?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.